🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To compare the safety of efficacy of abarelix versus goserelin plus bicalut...
Status
Completed
Location
Multiple Locations
Start Date
1999-01
Trial ID
NCT00841113
Treatments Being Tested
The purpose of the study is to examine the effect of testosterone treatment...
Status
Terminated
Location
Massachusetts General Hospital
Start Date
2006-09
Trial ID
NCT00438321
Treatments Being Tested
The purpose of this phase 3B trial was to see how well a new trial drug (de...
Status
Completed
Location
Alabama Research Center
Start Date
2009-04
Trial ID
NCT00833248
Treatments Being Tested
RATIONALE: Androgens can cause the growth of prostate cancer cells. Luteini...
Status
Completed
Location
The Jikei University School of Medicine
Start Date
2008-04
Trial ID
NCT00664456
Treatments Being Tested
RATIONALE: Hormones can stimulate the growth of prostate cancer cells. Horm...
Status
Completed
Location
Cross Cancer Institute
Start Date
1995-02-08
Trial ID
NCT00002633
The GOMIMP will be a Prospective, Randomized, Cross-over Trial to Explore t...
Status
Unknown
Location
The First Affiliated Hospital of Xiamen University
Start Date
2024-05
Trial ID
NCT06385847
The purpose of this open-label, multicenter, phase IIIb, single-arm study i...
Status
Recruiting
Location
Central Alabama Research
Start Date
2024-02-28
Trial ID
NCT05827081
Treatments Being Tested
Erlotinib attacks a part of cancer cells that helps them live and grow. Stu...
Status
Terminated
Location
Vanderbilt-Ingram Oncology Cool Springs
Start Date
2010-05
Trial ID
NCT01205685
RATIONALE: SU5416 may stop the growth of cancer by stopping blood flow to t...
Status
Completed
Location
Radiation Oncology
Start Date
2001-11
Trial ID
NCT00026377
Treatments Being Tested
Despite different clinical characteristics including the response to treatm...
Status
Unknown
Location
Institut Jules Bordet
Start Date
2021-01-14
Trial ID
NCT04551495
Treatments Being Tested